Neonatal intensive care unit (NICU) patients are at an especially high risk of acquiring colonization and infection by MRSA. Epidemiology of MRSA in NICU can be very complex because outbreaks can ...

Professor Hajo Grundmann, a world expert in infectious diseases, said MRSA in hospitals is already 'out of control' in many countries. But the emergence of stronger and more virulent strains could ...

When that happens, your infection will be said to be antibiotic resistant, and your physician will have to prescribe a different drug to combat it. MRSA: The Spread of Drug Resistance In fact ...

Oregon hospitals have reported a modest decline in health care-associated infections (HAIs) among patients in 2023, according ...

The gold standard antimicrobial, vancomycin, has several shortcomings that have prompted the development of newer agents for the treatment of MRSA disease. Moreover, the emergence of vancomycin ...

The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in collaboration with university startup NovoBiotic—has already proven itself ...